Tim-4 Effector B Cells Express a Th17-Like Proinflammatory Cytokine Module That Is Restrained by Nur77 2266650

Abstract Introduction B cells expressing various proinflammatory cytokines potentiate immune responses in infection, autoimmunity and transplantation. However, phenotypic markers for such effector B cells (Beffs) are lacking and regulation of their proinflammatory potential is uncharacterized. Tim-4+ B cells express IFNγ and promote islet allograft rejection. We now examine expression and regulation of other proinflammatory cytokines by Tim-4+ B cells. Methods RNAseq/ATACseq: +/- 24h stimulation with anti-IgM+IL-23. Cytokines: intracellular flow cytometry (IFC) of splenocytes stimulated 5h with PMA, ionomycin, BrefeldinA. Transplants: BALB/c islets under the kidney capsule of chemically diabetic B6 mice; heterotopic Bm12 hearts into B6 mice. Results Tim-4+ Beffs uniquely express RORgt, which along with IL-23, drive expression of a pathogenic Th17-like proinflammatory module comprising Il17a, Il17f, Il22, Csf2, Il6, and Il1b. RNAseq/ATACseq identified Nr4a1 (Nur77) as a potential TF regulating Tim-4+ B cells. Nur77floxCd19CRE+/- (Nur77 BKO) mice exhibited a 1.5X increase in Tim-4+ Beffs, and these had increased RORgt (2.5x), IL17(1.7x), IL22(2x), GM-CSF(1.5x), IL6(2x), & IL1b(2x) expression vs. Cre-controls (IFC). Notably, Tim1+ Breg frequency and IL-10 expression were decreased (30% & 60% respectively). Compared to Cre controls, Nur77 BKO mice exhibited shorter islet allograft survival (MST 14d vs 20d; p < 0.05) and accelerated rejection of BM12 hearts (MST 30d vs 65d; p < 0.01). In vitro data reveal tamoxifen-induced KO of B cell Nur77 acutely increases IL-17 expression, now enabling studies to determine how Nur77 regulates the Tim-4+ Beff transcriptome. Conclusion Tim-4 is a broad marker for Beffs that promote allograft rejection via expression of a pro-inflammatory module driven by IL-23 and RORgt. Nur77 constrains Tim-4+ Beffs and maintains a normal balance between Beffs and Bregs. This enhances our understanding of B cell biology and provides insight into immune regulation and tolerance. Funding Source R01 Topic Categories Transplantation Immunology (TRAN)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1099
Primary Topic
Nuclear Receptors and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tim-4 Effector B Cells Express a Th17-Like Proinflammatory Cytokine Module That Is Restrained by Nur77 2266650

David Rothstein, Qing Ding
The Journal of Immunology
Nuclear Receptors and Signaling
article

Tim-4 Effector B Cells Express a Th17-Like Proinflammatory Cytokine Module That Is Restrained by Nur77 2266650

David Rothstein, Qing Ding
article en

Abstract

Abstract Introduction B cells expressing various proinflammatory cytokines potentiate immune responses in infection, autoimmunity and transplantation. However, phenotypic markers for such effector B cells (Beffs) are lacking and regulation of their proinflammatory potential is uncharacterized. Tim-4+ B cells express IFNγ and promote islet allograft rejection. We now examine expression and regulation of other proinflammatory cytokines by Tim-4+ B cells. Methods RNAseq/ATACseq: +/- 24h stimulation with anti-IgM+IL-23. Cytokines: intracellular flow cytometry (IFC) of splenocytes stimulated 5h with PMA, ionomycin, BrefeldinA. Transplants: BALB/c islets under the kidney capsule of chemically diabetic B6 mice; heterotopic Bm12 hearts into B6 mice. Results Tim-4+ Beffs uniquely express RORgt, which along with IL-23, drive expression of a pathogenic Th17-like proinflammatory module comprising Il17a, Il17f, Il22, Csf2, Il6, and Il1b. RNAseq/ATACseq identified Nr4a1 (Nur77) as a potential TF regulating Tim-4+ B cells. Nur77floxCd19CRE+/- (Nur77 BKO) mice exhibited a 1.5X increase in Tim-4+ Beffs, and these had increased RORgt (2.5x), IL17(1.7x), IL22(2x), GM-CSF(1.5x), IL6(2x), & IL1b(2x) expression vs. Cre-controls (IFC). Notably, Tim1+ Breg frequency and IL-10 expression were decreased (30% & 60% respectively). Compared to Cre controls, Nur77 BKO mice exhibited shorter islet allograft survival (MST 14d vs 20d; p < 0.05) and accelerated rejection of BM12 hearts (MST 30d vs 65d; p < 0.01). In vitro data reveal tamoxifen-induced KO of B cell Nur77 acutely increases IL-17 expression, now enabling studies to determine how Nur77 regulates the Tim-4+ Beff transcriptome. Conclusion Tim-4 is a broad marker for Beffs that promote allograft rejection via expression of a pro-inflammatory module driven by IL-23 and RORgt. Nur77 constrains Tim-4+ Beffs and maintains a normal balance between Beffs and Bregs. This enhances our understanding of B cell biology and provides insight into immune regulation and tolerance. Funding Source R01 Topic Categories Transplantation Immunology (TRAN)

The Journal of ImmunologyVol. 215(Supplement_1)
University of Pittsburgh (US)
Openalex Percentile: Top 13%
Nuclear Receptors and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.